Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

571.36
-2.8000-0.49%
Pre-market: 575.023.66+0.64%05:38 EDT
Volume:1.66M
Turnover:953.31M
Market Cap:61.71B
PE:14.49
High:580.56
Open:576.35
Low:567.59
Close:574.16
Loading ...

2 Large-Cap Stocks with Solid Fundamentals and 1 to Brush Off

StockStory
·
17 Mar

Argus Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $1,000

MT Newswires Live
·
15 Mar

Regeneron Shares Fall After US Appeals Court Denies Request for Stay on Eylea Biosimilars

MT Newswires Live
·
15 Mar

BMO says Eylea court decision ‘modest negative’ for Regeneron

TIPRANKS
·
15 Mar

Jim Cramer On Regeneron Pharmaceuticals Inc. (REGN) – “I Want You to Own It”

Insider Monkey
·
14 Mar

Regeneron Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
14 Mar

BUZZ-Citi initiates Apogee with "buy" rating on potential for eczema drug

Reuters
·
13 Mar

BUZZ-Citigroup starts coverage of Kymera with $52 PT

Reuters
·
13 Mar

Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Scientific Research on Classifying Objects in Space, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem

GlobeNewswire
·
12 Mar

TSVT Up on Acquisition Agreement With BMY for $286 Million

Zacks
·
12 Mar

Regeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now

Insider Monkey
·
11 Mar

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
11 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group

Reuters
·
11 Mar

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
11 Mar

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-03-10

Reuters
·
10 Mar

AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies

Zacks
·
10 Mar

Regeneron, Sanofi presents results from ADEPT Phase 2/3 trial on Dupixent

TIPRANKS
·
10 Mar

Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
08 Mar

BUZZ- Some defensives outperform, even as indexes switch to gains

Reuters
·
08 Mar

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Zacks
·
07 Mar